Study Shows Cold T Cells May Provide Protection Against Covid-19

The high T-cell levels of the common cold may provide protection against Covid-19, a study by Imperial College London found Monday could provide information for the development of second-generation vaccines.

Immunity against Covid-19 is a complex picture, and while there is evidence of a drop in antibody levels six months after vaccination, T cells are thought to also play a vital role in providing protection.

The authors of the article present the first evidence that T cells induced by other coronaviruses can recognize SARS-CoV-2 and build protection against it.

The study, which began in September 2020, looked at the levels of cross-reactive T cells generated by previous colds in 52 household contacts with positive cases of Covid-19 shortly after infection to see if they develop an infection.

It was found that 26 people who did not develop the infection had significantly higher levels of these T cells than those who did. Imperial College did not say how long T-cell protection lasts.

“We found that high levels of pre-existing T cells created by the body when infected with other human coronaviruses, such as the common cold, can protect against Covid-19 infection,” said study author Dr. Ria Kundu.

The authors of the study, published in Nature Communications, said the internal proteins of the SARS-CoV-2 virus, which T cells target, could be an alternative target for vaccine manufacturers.

Current Covid-19 vaccines target a spike protein that mutates regularly, creating variants like Omicron that reduce the effectiveness of vaccines against symptomatic infection.

“In contrast, the intrinsic proteins that are targeted by the protective T cells that we have identified mutate much less,” said Professor Ajit Lalwani, co-author of the study.

“Hence they are very conservative between the various SARS-CoV-2 variants, including Omicron. Thus, new vaccines that include these conserved internal proteins will induce a broad protective T-cell response that should protect against current and future SARS-CoV-2 variants. ”

Source link

High-quality journalistic work cannot be free, otherwise it becomes dependent on the authorities or the oligarchs.
Our site is solely funded by advertising money.
Please disable your ad blocker to continue reading the news.
Best regards, editors